YD Bio Limited (YDES)
YDES trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.10
-3.63% on the day
Market cap
$432.1M
Small cap
Revenue · 2025
$597K
+16.9% on 2024
Net income · 2025
-$8.3M
-1392.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | YDES on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0002011674 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $597K |
| Net income | -$8.3M |
| Operating income | -$5.3M |
| Net margin | -1392.6% |
| Operating margin | -883.3% |
| Revenue growth | +16.9% |
| Cash | $6.0M |
| Total assets | $13.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 724.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B3 | 2026-09-01 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-30 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-01 |
Source: SEC EDGAR submissions feed, 80 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +7.8% |
| 1 month | +60.5% |
| 3 months | +157.7% |
| Year to date | -48.0% |
| 1 year | -65.7% |
| From 52-week high | -68.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| YDESW | YD Bio Limited Warrants | $0.6400 |
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| FLGT | Fulgent Genetics Inc. | $21.06 | -1.91% | $579.5M |
| BDSX | Biodesix Inc. | $25.00 | -2.72% | $263.8M |
| TLSI | TriSalus Life Sciences Inc. | $4.00 | -3.38% | $246.3M |
| XGN | Exagen Inc. | $8.48 | +2.79% | $205.4M |
| CSTL | Castle Biosciences Inc. | $32.88 | +0.37% | $1.0B |
| LMRI | Lumexa Imaging Holdings Inc. | $10.61 | -0.66% | $1.0B |
| TRUP | Trupanion Inc. | $26.57 | +1.06% | $1.2B |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier